Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US15265597Application Date: 2016-09-14
-
Publication No.: US10245317B2Publication Date: 2019-04-02
- Inventor: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
- Applicant: GlaxoSmithKline Biologicals s.a.
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE Rixensart
- Agency: Seed IP Law Group LLP
- Priority: GB0513069.5 20050627; GB0513071.1 20050627; GB0515556.9 20050728; GB0524204.5 20051128; GB0526040.1 20051221; GB0526041.9 20051221
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/02 ; C07H3/00 ; C12N7/00 ; A61K39/08 ; A61K39/09 ; A61K39/385 ; A61K39/095 ; A61K39/102 ; A61K39/116 ; A61K39/05 ; A61K39/29 ; A61K39/145 ; A61K39/12
Abstract:
The present application discloses an immunogenic composition comprising at least 2 different N. meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW which is/are conjugated through a linker to a carrier protein(s), and one or more different saccharides is/are selected from a second group consisting of MenA, MenC, MenY and MenW which is/are directly conjugated to a carrier protein(s).
Public/Granted literature
- US20170065714A1 IMMUNOGENIC COMPOSITION Public/Granted day:2017-03-09
Information query
